I agree with some of this, but the other element I see is there looks to be some sector-related influence... take a look at the recent performance of some of the other junior oncology stocks for example - e.g. BD1, IMM, IMU. Some of this sector weakness may be related to the recent CR's announced by these companies - creating negative sentiment, selling 'similar' stocks to free up funds to participate, etc.
RAC - Charts & Price Action, page-7210
-
- There are more pages in this discussion • 14,350 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $298.0M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.83 | $1.73 | $272.0K | 152.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9998 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |